Spots Global Cancer Trial Database for Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
Official Title: A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Study ID: NCT01084330
Study Description
Brief Summary: A clinical trial to determine the effectiveness and safety of AUY922 compared to other drugs known to be effective against gastric cancer in second line therapy for patients who have failed one line of chemotherapy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
USC/Kenneth Norris Comprehensive Cancer Center USC/Norris, Los Angeles, California, United States
University of California at Los Angeles Dept. of UCLA (4), Los Angeles, California, United States
Horizon Oncology Center, Lafayette, Indiana, United States
The Sidney Kimmel Cancer Center at Johns Hopkins Hospital Dept. of SKCC @ JHU, Baltimore, Maryland, United States
Clinical Research Alliance Dept.ofArenaOncologyAssoc(2), Lake Success, New York, United States
Baylor Health Care System/Sammons Cancer Center Baylor Texas Oncology, Dallas, Texas, United States
Tyler Cancer Center Dept.ofTylerCancerCtr. (2), Tyler, Texas, United States
Novartis Investigative Site, Adelaide, South Australia, Australia
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Bordeaux Cedex, , France
Novartis Investigative Site, Lyon Cedex, , France
Novartis Investigative Site, Toulouse Cedex 9, , France
Novartis Investigative Site, Erlangen, , Germany
Novartis Investigative Site, Ulm, , Germany
Novartis Investigative Site, Genova, GE, Italy
Novartis Investigative Site, Modena, MO, Italy
Novartis Investigative Site, Pisa, PI, Italy
Novartis Investigative Site, Roma, RM, Italy
Novartis Investigative Site, Napoli, , Italy
Novartis Investigative Site, Suwon, Gyeonggi-do, Korea, Republic of
Novartis Investigative Site, Suwon, Gyeonggi-do, Korea, Republic of
Novartis Investigative Site, Seoul, Korea, Korea, Republic of
Novartis Investigative Site, Utrecht, , Netherlands
Novartis Investigative Site, Moscow, , Russian Federation
Novartis Investigative Site, Moscow, , Russian Federation
Novartis Investigative Site, Singapore, , Singapore
Novartis Investigative Site, Bellinzona, , Switzerland
Novartis Investigative Site, Kuei-Shan Chiang, Taoyuan/ Taiwan ROC, Taiwan
Novartis Investigative Site, Tainan, , Taiwan
Novartis Investigative Site, Taipei, , Taiwan
Novartis Investigative Site, Taipei, , Taiwan
Novartis Investigative Site, Ankara, , Turkey
Novartis Investigative Site, Surrey, England, United Kingdom
Novartis Investigative Site, Sutton, Surrey, United Kingdom
Novartis Investigative Site, Glasgow, , United Kingdom
Novartis Investigative Site, Leicester, , United Kingdom
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
